Technological advancements in the Non-Small Cell Lung Cancer industry are shaping the future market landscape. The report evaluates innovation-driven growth and how emerging technologies are transform
We measured the microbiome in lung tumor and normal lung tissue from stage II NSCLC patients, to examine associations of the lung microbiome with lung cancer recurrence.
We measured the microbiome in lung tumor and normal lung tissue from stage II NSCLC patients, to examine associations of the lung microbiome with lung cancer recurrence.
To investigate the relationship between lung microbiome and the phenotype of inflammatory stromal infiltrate, we studied 26 pairs of DNA samples from NSCLC (non-small cell lung cancer) and adjacent ti